Program

Click here to download the program:

8th HIV & Aging - Program

Monday 2 October - Day 1

8:30 Opening of the workshop
Session 1: Biological aging
8:45

Phenotype of aging
George Kuchel, MD - UCONN Health Center of Aging, Farmington, CT, USA

9:15

Clinical Trials Targeting Aging to Extend Healthy Lifespan
Jamie Justice, PhD - Wake Forest School of Medicine, Winston-Salem, NC, USA

9:45 The biology of superagers
Nir Barzilai, MD - Albert Einstein College of Medicine, New York, NY, USA
10:15Discussion
10:30Coffee break
Session 2: Biological aging : abstract-driven presentations
11:00Inability of ART to Restore Age-Appropriate Epigenetic Patterns in HIV-Infected Adults
Dr Beth Jamieson-Karavodin, David Geffen - School of Medicine at UCLA, USA
#1
11:15Mitochondrial DNA variation associated with gait speed decline among older HIV-infected non-Hispanic white males
Jing Sun - Johns Hopkins Bloomberg School Of Public Health, USA
#2
11:30Limited evidence of biological aging in early-treated HIV-infected children
Stephanie Shiau - Columbia University, USA
#3
11:45 Metformin suppresses human cytomegalovirus infection: an underlying mechanism for metformin’s “geroprotective” effect?
Sean Leng - Johns Hopkins University School of Medicine, USA
#4
12:00 Discussion
12:15 Group picture
12:30 Lunch
Session 3: Aging and CNS safety of HIV interventions
13:30HIV eradication strategies and the CNS
Serena Spudich, MD - Yale University, New Haven, NY, USA
14:00Antiretroviral neurotoxicity in aging adults
Scott Letendre, MD - University of California, San Diego, CA, USA
14:30Discussion
14:45Coffee break and poster viewing session 1
Session 4: Aging and CNS safety of HIV interventions: abstract-driven presentations
15:45OMICS in the context of Aging and Alzheimer's disease
Madhav Thambisetty, MD - NIA / NIH, Baltimore, MD, USA
 Abstract driven presentations:
16:15Common SNPs in the HFE (Hemochromatosis) Gene are Associated with Neurocognitive Impairment and Aging-Related Neurodegenerative Processes in HIV+ Adults
Asha Kallianpur  - Cleveland Clinic Foundation, USA
#5
16:30Lower cerebral blood flow and elevated chronic monocyte activation correlate with cognitive impairment in well-controlled older HIV+ individuals
Tricia Burdo - Temple University Lewis Katz School Of Medicine, USA
#6
16:45Cognition, Mood and Quality of Life in 706 HIV+ Men in Canada
Marie-Josée Brouillette - McGill University Health Centre, Canada
#7
17:00Cognitive Impairment in Symptomatic HIV Over age 60
Shireen Javandel - UC San Francisco, Memory & Aging Center, USA
#8
17:15Discussion
17:30Welcome drinks and poster viewing session 2
19:00Workshop dinner (on pre-registration only)

Tuesday 3 October - Day 2

Session 5: The effect of exercise and diet on aging
8:00 

Exercise and aging
Wendy Kohrt, PhD - University of Colorado, Denver, CO, USA

8:30 Stress and aging
Gretchen Neigh, PhD - Virginia Commonwealth University, Richmond, VA, USA
9:00Interrelationships of nutrition and aging
Connie Bales, PhD - Duke University, Durham, NC, USA
9:30

Discussion

10:00Coffee break and poster viewing session 3
Session 6: The effect of exercise and diet on aging: abstract-driven presentations
10:45Adherence to recommendations from comprehensive geriatric assessment in an HIV+ population
Christiana Bitas - Weill Cornell Medical College, USA
#9
11:00Lean mass declines consistently over 10 Years in HIV-Infected adults on antiretroviral therapy, with patterns differing by sex
Jordan Lake - UTHealth, USA
#10
11:15Steps count is associated with adverse health outcomes in HIV patients better than traditional HIV variables
Giovanni Guaraldi - University of Modena, Italy
#11
11:30The relationships between CD4+ and CD8+ T-cell responses to human cytomegalovirus, circulating inflammatory markers, and frailty in HIV- and HIV+ men in the Multicenter AIDS Cohort Study
Joseph Margolick - Johns Hopkins Bloomberg School of Public Health, USA
#12
11:45 Discussion
12:00Lunch

Session 7: Delivering research progress to patients
Chairs: Jules Ievin, Julian Falutz, Kristine Erlandson

13:00Current reality: The San Francisco experience
Meredith Greene, MD - UCSF School of Medicine, San Francisco, CA, USA
13:30

Current reality: The New York experience
Eugenia Siegler, MD - Weill Cornell Medical College, New York, NY, USA

Round Table Discussion:

14:00The community perspective
Jules Levin, MS - NATAP, New York, USA.
14:20

The researcher perspective
Phyllis Tien, MD - University of California, San Francisco, CA, USA

14:40The NIH perspective
Maureen Goodenow, PhD - NIH / OAR, Bethesda, MD, USA
15:00Panel discussion
15:30Closing remarks
INVITED SPEAKERS